ofloxacin has been researched along with Mycobacterium Infections in 19 studies
Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.
Mycobacterium Infections: Infections with bacteria of the genus MYCOBACTERIUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A systemic antibiotic, 1 g levofloxacin daily, had been started at the initial abscess operation." | 3.71 | [Osteomyelitis of the tibial head caused by Mycobacterium haemophilium in a patient with AIDS]. ( Brade, V; Enzensberger, R; Gruschke, A, 2002) |
| "Tubercular sternal osteomyelitis is a rare manifestation of tuberculosis." | 1.35 | Sternal tuberculosis. ( Howell, JM; Mohammadi, A, 2009) |
| "Multiple injections of ofloxacin (subcutaneous or oral) in combination with a Lactobacillus casei preparation, LC9018 (subcutaneous), in mice infected intravenously with Mycobacterium fortuitum led to a marked delay in the incidence of spinning disease, a lowered incidence of gross renal lesions, and an increase in the rate of elimination of organisms from the kidneys." | 1.28 | Effect of ofloxacin combined with Lactobacillus casei against Mycobacterium fortuitum infection induced in mice. ( Saito, H; Sato, K; Tomioka, H, 1990) |
| "A 58-year-old man with pulmonary disease due to Mycobacterium fortuitum was treated successfully with ofloxacin (0." | 1.27 | Ofloxacin and the treatment of pulmonary disease due to Mycobacterium fortuitum. ( Ichiyama, S; Tsukamura, M, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (36.84) | 18.7374 |
| 1990's | 6 (31.58) | 18.2507 |
| 2000's | 3 (15.79) | 29.6817 |
| 2010's | 3 (15.79) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tam, PM | 1 |
| Young, AL | 1 |
| Cheng, L | 1 |
| Congdon, N | 1 |
| Lam, PT | 1 |
| Disratthakit, A | 1 |
| Doi, N | 1 |
| Kelley, CF | 1 |
| Armstrong, WS | 1 |
| Eaton, ME | 1 |
| Gruschke, A | 1 |
| Enzensberger, R | 1 |
| Brade, V | 1 |
| Tam, WO | 1 |
| Yew, WW | 4 |
| Yam, WC | 1 |
| Yuen, KY | 1 |
| Wong, PC | 1 |
| Tse, TF | 1 |
| Mohammadi, A | 1 |
| Howell, JM | 1 |
| Padeĭskaia, EN | 1 |
| Padełskaya, EN | 1 |
| Tsukamura, M | 2 |
| Yamori, S | 1 |
| Wallace, RJ | 1 |
| Bedsole, G | 1 |
| Sumter, G | 1 |
| Sanders, CV | 1 |
| Steele, LC | 1 |
| Brown, BA | 1 |
| Smith, J | 1 |
| Graham, DR | 1 |
| Tomioka, H | 3 |
| Sato, K | 3 |
| Saito, H | 3 |
| Kwan, SY | 3 |
| Ma, WK | 3 |
| Lui, KS | 1 |
| Suen, HC | 1 |
| Heap, BJ | 1 |
| Aung-khin, M | 1 |
| Mok, CK | 2 |
| Khin, MA | 1 |
| Watanabe, T | 1 |
| Ichiyama, S | 1 |
2 reviews available for ofloxacin and Mycobacterium Infections
| Article | Year |
|---|---|
[Value of ciprofloxacin in the therapy of tuberculosis and other mycobacterioses].
Topics: Anti-Infective Agents; Ciprofloxacin; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium | 1997 |
[Ofloxacin in mycobacteriosis therapy].
Topics: Animals; Anti-Infective Agents; Clinical Trials as Topic; Disease Models, Animal; Humans; Leprosy, T | 1997 |
17 other studies available for ofloxacin and Mycobacterium Infections
| Article | Year |
|---|---|
Tsukamurella: an unrecognized mimic of atypical mycobacterial keratitis? The first case report.
Topics: Actinomycetales; Actinomycetales Infections; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Cor | 2010 |
In vitro activities of DC-159a, a novel fluoroquinolone, against Mycobacterium species.
Topics: Aminopyridines; Antitubercular Agents; Aza Compounds; Drug Resistance, Multiple, Bacterial; Fluoroqu | 2010 |
Disseminated Mycobacterium haemophilum infection.
Topics: Acquired Immunodeficiency Syndrome; Anti-Bacterial Agents; Anti-HIV Agents; Cellulitis; Clarithromyc | 2011 |
[Osteomyelitis of the tibial head caused by Mycobacterium haemophilium in a patient with AIDS].
Topics: Abscess; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antitubercular Agents; Clarit | 2002 |
Pacemaker infections due to rapidly growing mycobacteria: further experience.
Topics: Acetamides; Aged; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Female; Humans; | 2007 |
Sternal tuberculosis.
Topics: Abscess; Adult; Anti-Bacterial Agents; Antitubercular Agents; Drug Therapy, Combination; Humans; Mal | 2009 |
[Chemotherapeutic regimens for nontuberculous mycobacterial infection based on in-vitro susceptibility test results].
Topics: Drug Resistance, Microbial; Drug Therapy, Combination; Enviomycin; Ethambutol; Humans; Isoniazid; My | 1990 |
Activities of ciprofloxacin and ofloxacin against rapidly growing mycobacteria with demonstration of acquired resistance following single-drug therapy.
Topics: Adult; Aged; Ciprofloxacin; Drug Resistance, Microbial; Female; Humans; Male; Microbial Sensitivity | 1990 |
Effect of ofloxacin combined with Lactobacillus casei against Mycobacterium fortuitum infection induced in mice.
Topics: Adjuvants, Immunologic; Administration, Oral; Animals; Drug Synergism; Female; Injections, Subcutane | 1990 |
Ofloxacin therapy of Mycobacterium fortuitum infection: further experience.
Topics: Adult; Aged; Female; Humans; Male; Middle Aged; Mycobacterium Infections; Mycobacterium Infections, | 1990 |
[Rifabutine in the treatment of mycobacterial infections resistant to rifampicin. Preliminary results. Group for the Study and Treatment of Resistant Mycobacterial Infections (GETIM)].
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Drug Resistance, Microbial; Drug Therapy, Combinati | 1989 |
Mycobacterium simiae as a cause of intra-abdominal disease: a case report.
Topics: Abdomen; Adult; Ascitic Fluid; Drug Therapy, Combination; Female; Humans; Isoniazid; Kanamycin; Myco | 1989 |
Combination of ofloxacin and amikacin in the treatment of sternotomy wound infection.
Topics: Adult; Aged; Amikacin; Cardiac Surgical Procedures; Drug Combinations; Female; Humans; Injections, I | 1989 |
Single daily-dose ofloxacin monotherapy for Mycobacterium fortuitum sternotomy infection.
Topics: Drug Administration Schedule; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycoba | 1989 |
[In vitro and in vivo activities of norfloxacin, ofloxacin and ciprofloxacin against various mycobacteria].
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Microbial; Female; Mice; Mycobacteri | 1987 |
Ofloxacin and the treatment of pulmonary disease due to Mycobacterium fortuitum.
Topics: Humans; Lung Diseases; Male; Middle Aged; Mycobacterium Infections; Ofloxacin; Oxazines; Radiography | 1987 |
[Environmental mycobacteria in Korea--II. Therapeutic effects of ofloxacin against infections due to isolates].
Topics: Animals; Environmental Microbiology; Korea; Mice; Mice, Inbred Strains; Mycobacterium; Mycobacterium | 1987 |